Actively Recruiting
Efficacy of Dihydroartemisinin for Treating Acne Vulgaris
Led by Shanghai Zhongshan Hospital · Updated on 2025-06-05
60
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Acne Vulgaris in adults. The main question it aims to answer is: • Does DHA improve the acne severity by at least one grade after treatment. Researchers will treat patients who are clinically diagnosed as Acne Vulgaris to see if DHA works to alleviate the symptoms of Acne Vulgaris. Participants will: * Take DHA every day for 3 months * Visit the clinic once every month for checkups and tests
CONDITIONS
Official Title
Efficacy of Dihydroartemisinin for Treating Acne Vulgaris
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinically diagnosed with acne vulgaris
- For female patients, no plans for pregnancy within the next 6 months
- Age between 18 and 40 years old
You will not qualify if you...
- Use of sex hormones or other systemic acne medications within the past 3 months
- Use of topical acne medications within the past 2 weeks
- Pregnant or breastfeeding women
- Known severe diseases of vital organs (heart, liver, kidney) or malignancies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
L
Lujuan GAO, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here